Baolingbao Biology Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -0.77%

Baolingbao Biology Co Ltd (002286) has an Asset Resilience Ratio of -0.77% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Baolingbao Biology Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥-20.42 Million

≈ $-2.99 Million USD Cash + Short-term Investments

Total Assets

CN¥2.66 Billion

≈ $389.08 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2023)

This chart shows how Baolingbao Biology Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Baolingbao Biology Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Baolingbao Biology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002286 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-20.42 Million	-0.77%
Total Liquid Assets	CN¥-20.42 Million	-0.77%

Asset Resilience Insights

Limited Liquidity: Baolingbao Biology Co Ltd maintains only -0.77% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Baolingbao Biology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Baolingbao Biology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Baolingbao Biology Co Ltd (2013–2023)

The table below shows the annual Asset Resilience Ratio data for Baolingbao Biology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.77%	CN¥-20.42 Million ≈ $-2.99 Million	CN¥2.66 Billion ≈ $389.08 Million	-4.29pp
2021-12-31	3.52%	CN¥106.67 Million ≈ $15.61 Million	CN¥3.03 Billion ≈ $443.24 Million	+3.73pp
2020-12-31	-0.21%	CN¥-5.48 Million ≈ $-802.34K	CN¥2.62 Billion ≈ $382.76 Million	+0.09pp
2019-12-31	-0.30%	CN¥-7.62 Million ≈ $-1.12 Million	CN¥2.52 Billion ≈ $368.57 Million	+0.10pp
2018-12-31	-0.41%	CN¥-10.51 Million ≈ $-1.54 Million	CN¥2.58 Billion ≈ $377.43 Million	-0.29pp
2017-12-31	-0.12%	CN¥-2.44 Million ≈ $-357.60K	CN¥2.11 Billion ≈ $308.31 Million	0.00pp
2016-12-31	-0.11%	CN¥-2.15 Million ≈ $-314.40K	CN¥1.93 Billion ≈ $282.65 Million	-0.02pp
2015-12-31	-0.09%	CN¥-1.81 Million ≈ $-265.48K	CN¥1.91 Billion ≈ $280.01 Million	+0.01pp
2014-12-31	-0.11%	CN¥-1.91 Million ≈ $-279.19K	CN¥1.77 Billion ≈ $258.44 Million	+0.01pp
2013-12-31	-0.12%	CN¥-2.00 Million ≈ $-292.89K	CN¥1.68 Billion ≈ $245.28 Million	--

pp = percentage points

About Baolingbao Biology Co Ltd

SHE:002286 China Biotechnology

Market Cap

$496.75 Million

CN¥3.39 Billion CNY

Market Cap Rank

#12425 Global

#3650 in China

Share Price

CN¥8.92

Change (1 day)

-2.19%

52-Week Range

CN¥8.67 - CN¥12.87

All Time High

CN¥23.40